Staining for the proliferation marker Ki-67 revealed a significant reduction in tumor cell proliferation following Bcl9@TP monotherapy, with the Ki-67 index decreasing by approximately 55% compared to the control group. This evidence concerns the gene BCL9 and neoplasm.